Exchange: NASDAQ·Updated 05:38 PM EDT
MPLT logo

MPLTMapLight Therapeutics Inc.

$36.08
$0.24
(0.67%)
Today
Closed $36.08
$0.00
(0.00%)
After Hours
EarningsAug 13
Mkt Cap$1.53B
Vol504,841.00
News
all
press releases
Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout?
Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout...
Yahoo! Finance: News
News Placeholder
More News
News Placeholder
MapLight Therapeutics Autism Drug Shows Mixed Potential In Adolescents
MapLight's ML-004 misses its main autism study goal but showed notable irritability improvements in adolescents.read more...
Benzinga
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by HC Wainwright
HC Wainwright raised shares of Maplight Therapeutics to a "strong-buy" rating in a research report on Monday...
MarketBeat
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 5.5% - Here's What Happened
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 5.5% - Here's What Happened...
MarketBeat
News Placeholder
Jonathan Gillis Sells 51,900 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Jonathan Gillis sold 51,900 shares of Maplight Therapeutics stock in a transaction on Monday, April 27th. The stock was sold at an...
MarketBeat
News Placeholder
Anatol Kreitzer Sells 45,422 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Anatol Kreitzer sold 45,422 shares of the company's stock in a transaction that occurred on Monday, April 27th. The stock was sold...
MarketBeat
News Placeholder
Insider Selling: Maplight Therapeutics (NASDAQ:MPLT) Insider Sells 17,935 Shares of Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Jonathan Gillis sold 17,935 shares of the company's stock in a transaction dated Tuesday, April 28th. The shares were sold at an...
MarketBeat
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Hits New 52-Week High - What's Next?
Maplight Therapeutics (NASDAQ:MPLT) Reaches New 52-Week High - Should You Buy...
MarketBeat
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 12.8% - Still a Buy?
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 12.8% - Here's Why...
MarketBeat
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down - Here's Why
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down - Here's Why...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.